Inhibition of the mutated c-KIT kinase in AML1-ETO–positive leukemia cells restores sensitivity to PARP inhibitor

Margaret Nieborowska-Skorska, Elisabeth M. Paietta, Ross L. Levine, Hugo F. Fernandez, Martin S. Tallman, Mark R. Litzow, Tomasz Skorski

Research output: Contribution to journalArticle

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)4050-4054
Number of pages5
JournalBlood Advances
Volume3
Issue number23
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Hematology

Cite this

Nieborowska-Skorska, M., Paietta, E. M., Levine, R. L., Fernandez, H. F., Tallman, M. S., Litzow, M. R., & Skorski, T. (2019). Inhibition of the mutated c-KIT kinase in AML1-ETO–positive leukemia cells restores sensitivity to PARP inhibitor. Blood Advances, 3(23), 4050-4054. https://doi.org/10.1182/bloodadvances.2019000756